인체폐암세포 NCI-H460 및 A549의 apoptosis 유발에 미치는 參_補肺湯의 영향

참고문헌 (64)

1. "암 예방과 치료법", pp.128~ (2007), 비즈북
2. "2005최신지견내과학", pp.32~ (2005), 고려의학
3. "머크 매뉴얼", pp.702~ (2002), 한우리
4. "난경연구집성", pp.768~769 (2002), 주민출판사
5. "동의폐계내과학", pp.87~ (2004), 도서출판 국진
6. "분자생물학적 측면에서의 폐암의 발생", 27(3), pp.152~157 (1999)
7. "인체폐암세포의 성장에 미치는 위경탕의 영향에 관한 연구", 18(2), pp.553~560 (2004)
8. "인체폐암세포의 증식 및 prostaglandin E2 생성에 미치는 청조구폐탕의 영향에 관한 연구", 20(4), pp.966~972 (2006)
9. "인체폐암세포에서 Bcl-2 발현저하 및 caspase 활성을 통한 청조구폐탕의 apoptosis 유발에 관한 연구", 21(1), pp.93~97 (2007)
10. "어성초 메탄올 추출물에 의한 A549 인체 폐암세포 사멸유도에 관한 연구", 20(6), pp.1584~1592 (2006)
11. "천금위경탕의 인체 폐암 세포 증식억제에 관한 연구", 18(40), pp.1147~1153 (2004)
12. "길경이 인체 폐암세포에 미치는 영향에 대한 실험적 연구", 17(4), pp.1019~1030 (2003)
13. "Multiple pathways to apoptosis", pp.461~76 (1993)
14. "The role of the endonuclease", pp.593~608 (1990)
15. "Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis", pp.3743~51 (1994)
16. "Premature p34cdc2 activation required for apoptosis", pp.1143~45 (1994)
17. "Bcl-2 family proteins", 17, pp.3225~3236 (1998)
18. "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", 80, pp.293~299 (1995)
19. "WAF1", CIP1 is induced in p53-mediated G1 arrest and apoptosis, 1994, 1169~74
20. "The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis", 275, pp.1132~1136 (1997)
21. "Apoptosis by death factor", 88, pp.355~365 (1997)
22. Tsujimoto, Y, "Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria", 3, pp.697~707 (1998)
23. Cheng, J.Q.,, "Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase", Akt pathway, 2002, pp.5, 131~146
24. Salvesen, G.S, "IAP proteins: blocking the road to death's door", 3, pp.401~410 (2002)
25. Holcik, M.,, "XIAP: apoptotic brake and promising therapeutic target", 6, pp.253~261 (2001)
26. LaCasse, E.C.,, "The inhibitors of apoptosis (IAPs) and their emerging role in cancer", 17, pp.3247~3259 (1998)
27. Giercksky, K.E, "COX-2 inhibition and prevention of cancer", 5, pp.821~833 (2001)
28. Turini, M.E, "Cyclooxygenase-2: a therapeutic target", 53, pp.35~57 (2002)
29. Chiarugi, V.,, "Cox-2, iNOS and p53 as play-makers of tumor angiogenesis", 2, pp.715~719 (1998)
30. Surh, Y.J.,, "Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down- regulation of COX-2 and iNOS through suppression of NF-κB activation", pp.243~ (2001)
31. Thun, M.J.,, "Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues", 94, pp.252~266 (2002)
32. Poole, J.C.,, "Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)", 269, pp.1~12 (2001)
33. Kyo, S, "Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy", 21, pp.688~697 (2002)
34. Fabian D, "Apoptotic processes during mammalian preimplantation development", 64, pp.221~231 (2005)
35. Sheikh MS, "Death receptors as targets of cancer therapeutics", 4, pp.97~104 (2004)
36. Klas C, "Activation interferes with the APO-1 pathway in mature human T cells", 5, pp.625~30 (1993)
37. Daniel PT, "Activation induces sensitivity toward APO-1 -mediated apoptosis in human B cells", j immu(l), pp.5624~32 (1994)
38. Wiley SR,, "Identification and characterization of a new member of the TNF family that induces apoptosis", 3, pp.673~682 (1995)
39. Ashkenazi A,, "Safety and antitumor activity of recombinant soluble Apo2 ligand", 104, pp.155~162 (1999)
40. Ashkenazi A, "Death receptors: signaling and modulation", 281, pp.1305~1308 (1998)
41. Kimberley FC, "Following a TRAIL: update on a ligand and its five receptors", 14, pp.359~372 (2004)
42. Tibbetts MD, "The death effector domain protein family: regulators of cellular homeostasis", 4, pp.404~409 (2003)
43. Fulda S, "Exploiting death receptor signaling pathways for tumor therapy", 1705, pp.27~41 (2004)
44. Belka C, "Apoptosis-modulating agents in combination with radiotherapy -current status and outlook", 58, pp.542~554 (2004)
45. Walczak H,, "Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo", 5, pp.157~163 (1999)
46. "Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c", 391, pp.496~499 (1998)
47. "Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells", 11, pp.1031~1039 (2004)
48. "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents", 74, pp.957~67 (1993)
49. "Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death", 1644, pp.133~147 (2004)
50. "Mechanisms controlling cellular suicide: role of Bcl-2 and caspases", 54, pp.427~445 (1998)
51. "Bcl-2 and the ICE family of apoptotic regulators: making a connection", 7, pp.52~58 (1997)
52. "Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance Bull Cancer", 92, pp.219~226 (2005)
53. "Yama", CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase, 1995, pp.81, 801~809
54. "Specific proteolytic cleavage of poly an early marker of chemotherapy-induced apoptosis", ottavia(y), pp.3976~85 (1993)
55. "Cleavage of poly polymerase by a proteinase with properties like ICE", pp.346~7 (1994)
56. "Cell adhesion molecules in the development and progression of malignant melanoma", 18, pp.345~357 (1999)
57. "E-cadherin-catenin cell-cell adhesion complex and human cancer", 87, pp.992~1005 (2000)
58. "Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells", 31, pp.519~529 (1999)
59. "Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation", 57, pp.5465~5468 (1997)
60. "Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells", 30, pp.990~1000 (2002)
61. "Proteolytic cleavage of phospholipase C-gamma1 during apoptosis in Molt-4 cells", 14, pp.1083~1092 (2000)
62. "Apoptotic DNA fragmentation", 256, pp.12~18 (2000)
63. "The DFF40", CAD endonuclease and its role in apoptosis, 2000, pp.47, 1037~1044
64. "Discovery, regulation, and action of the major apoptotic nucleases DFF40", CAD and endonuclease G, 2005, pp.94, 1078~1087

관련 논문AI추천